Bivalent COVID-19 Boosters Help Keep Older People Out of Hospitals, CDC Says

The updated COVID-19 booster shots give adults ages 65 and older the greatest level of protection against hospitalization, according to new U.S. government data. Bivalent boosters were 73% effective at preventing hospitalizations due to COVID in this group of older adults compared with people of the same age who got two or more doses of … Read more

This App Is the Newest Way to Treat Nightmares

Jacquie Baker, a former Air Force engineer, has had nightmares four or five nights a week for nearly a decade. The scenarios vary, but the feeling of helplessness is always the same: she’ll watch someone get murdered, or she’ll forget her pre-flight checklist and the plane she’s riding will crash. “I started having skin issues, … Read more

You Can Now Get Free COVID-19 Tests Through the Government Again

WASHINGTON — The Biden administration is again making some free COVID-19 tests available to all U.S. households as it unveils its contingency plans for potential coronavirus surges this winter. After a three-month hiatus, the administration is making four rapid virus tests available through covidtests.gov starting Thursday, a senior administration official said. The official spoke on … Read more

Long COVID Has Contributed to More Than 3,500 U.S. Deaths

Long COVID—a condition with symptoms ranging from respiratory to neurological, from crushing fatigue to chronic pain—can be debilitating. And in some cases, according to a new report from the National Center for Health Statistics (NCHS), Long COVID may even be fatal. From January 2020 through June 2022, Long COVID contributed to more than 3,500 deaths … Read more

Moderna’s mRNA Skin Cancer Vaccine Shows Early Promise in a New Study

Coming off the success of its mRNA vaccine for COVID-19, Moderna announced on Dec. 13 that it achieved encouraging results when it turned its vaccine technology against cancer. The company reported in a release that among 157 people with stage 3 or stage 4 melanoma, a personalized cancer vaccine that Moderna developed with Merck—created using … Read more

The Case for Cautious COVID Optimism This Winter

At this time last year and two years ago, daily new infections and COVID-related hospitalizations were already accelerating at a fast clip. BQ.1 and BQ.1.1, the latest Omicron subvariants, came to comprise the majority of cases during a relative lull in the pandemic. Combined with a Thanksgiving Holiday that saw the most travelers since the … Read more